Debate Over Heart Bypass Surgery Methods Remains Open

Cardiovascular Week reports that new research from the University of Virginia has shed light on the ongoing debate over the efficacy of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) for coronary revascularization. The study found that randomized controlled trials (RCTs) comparing the two methods have yielded mixed results, with some trials supporting CABG and others suggesting no significant difference between the two approaches.

Key Takeaways:

  • The fragility index (FI) was used to measure the robustness of RCTs comparing PCI and CABG, with a higher FI indicating a more robust result.
  • Of 314 trials identified in a PubMed query, 9 met inclusion criteria and were used to calculate FIs for major adverse cardiovascular or cerebrovascular event outcomes.
  • The average FI for major adverse cardiac events supporting CABG was 18, while no trials significantly supported PCI over CABG in the primary outcome of major adverse cardiac events.
  • The study's findings suggest that CABG is more robust than PCI for coronary revascularization, but that patient dependence and multifactorial considerations still dominate the debate.
  • Additional information can be obtained by contacting Raza M. Ahmad, Division of Cardiac Surgery, University of Virginia, Charlottesville, Virginia.
  • Researchers from the University of Virginia and the Journal of Surgical Research contributed to the study.

Statistics:

  • 314 trials were identified from a PubMed query using the search terms 'PCI,' 'CABG,' and 'RCT' with a filter applied for the last 20 years.
  • 9 trials met inclusion criteria and were used to calculate FIs for major adverse cardiovascular or cerebrovascular event outcomes.
  • The average FI for major adverse cardiac events supporting CABG was 18.
  • No trials significantly supported PCI over CABG in the primary outcome of major adverse cardiac events.

Sources:

  • NewsRx. New Findings from University of Virginia in the Area of Heart Bypass Surgery Reported (How "Fragile" is the Debate Against Coronary Artery Bypass Grafting?). Cardiovascular Week. November 3, 2025; p 51.
  • How "Fragile" is the Debate Against Coronary Artery Bypass Grafting? Journal of Surgical Research, 2025;315:615-620.